Plasma Alzheimer's disease biomarkers and cognitive progression in Parkinson's disease

被引：0
|
作者：
Pilotto, A.
Ashton, N. J.
Lupini, A.
Battaglio, B.
Gipponi, S.
Cottini, E.
Grossi, I.
Salvi, A.
de Petro, G.
Pizzi, M.
Blennov, K.
Gonzalez, M.
Aarsland, D.
Zetterberg, H.
Padovani, A.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1243
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [1] Plasma biomarkers of disease progression in Parkinson's disease
    Lupini, A.
    Ashton, N.
    Pilotto, A.
    Battaglio, B.
    Zatti, C.
    Gipponi, S.
    Cottini, E.
    Grossi, I.
    Salvi, A.
    De Petro, G.
    Pizzi, M.
    Blennow, K.
    Zetterberg, H.
    Padovani, A.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S655 - S656
  • [2] Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
    Yasuaki Mizutani
    Reiko Ohdake
    Harutsugu Tatebe
    Atsuhiro Higashi
    Sayuri Shima
    Akihiro Ueda
    Mizuki Ito
    Takahiko Tokuda
    Hirohisa Watanabe
    [J]. Journal of Neurology, 2023, 270 : 5461 - 5474
  • [3] Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
    Mizutani, Yasuaki
    Ohdake, Reiko
    Tatebe, Harutsugu
    Higashi, Atsuhiro
    Shima, Sayuri
    Ueda, Akihiro
    Ito, Mizuki
    Tokuda, Takahiko
    Watanabe, Hirohisa
    [J]. JOURNAL OF NEUROLOGY, 2023, 270 (11) : 5461 - 5474
  • [4] Biomarkers for Alzheimer's disease and Parkinson's disease
    Growdon, John H.
    Irizarry, Michael C.
    Scherzer, Clemens
    [J]. ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES, 2008, 57 : 169 - 174
  • [5] Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
    Lim, Nicholas S.
    Swanson, Christine R.
    Cherng, Hua-Ren
    Unger, Travis L.
    Xie, Sharon X.
    Weintraub, Daniel
    Marek, Ken
    Stern, Matthew B.
    Siderowf, Andrew
    Trojanowski, John Q.
    Chen-Plotkin, Alice S.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (05): : 346 - 355
  • [6] Biomarkers of rapid progression of cognitive decline in Parkinson's disease
    Martinez-Horta, S.
    Sampedro, F.
    Pagonabarraga Mora, J.
    Marin-Lahoz, J.
    Horta-Barba, A.
    Bejr-Kasem, H.
    Aracil, I.
    Perez-Perez, J.
    Boti, M. A.
    Kulisevsky, J.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S592 - S593
  • [7] IMAGING AND COGNITIVE BIOMARKERS AS PREDICTORS OF PROGRESSION TO ALZHEIMER'S DISEASE
    Rowe, C. C.
    Ellis, K.
    Brown, B.
    Bourgeat, P.
    Jones, G.
    Salvado, O.
    Martins, R.
    Masters, C. L.
    Ames, D.
    Villemagne, V. L.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 : 13 - 13
  • [8] Imaging and cognitive biomarkers as predictors of progression to Alzheimer's disease
    Rowe, Christopher
    Ellis, Kathryn
    Brown, Belinda
    Bourgeat, Pierrick
    Faux, Noel
    Martins, Ralph
    Salvado, Olivier
    Masters, Colin
    Ames, David
    Villemagne, Victor
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [9] Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers
    Pena-Bautista, Carmen
    alvarez, Lourdes
    Baquero, Miguel
    Ferrer, Ines
    Garcia, Lorena
    Hervas-Marin, David
    Chafer-Pericas, Consuelo
    [J]. JOURNAL OF NEUROCHEMISTRY, 2021, 157 (06) : 2187 - 2194
  • [10] Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
    Pai-Yi Chiu
    Fu-Chi Yang
    Ming-Jang Chiu
    Wei-Che Lin
    Cheng-Hsien Lu
    Shieh-Yueh Yang
    [J]. Scientific Reports, 12
12345